The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'October, 2017'. If you still can't find what you are looking for, try using the search box.
Oxford Immunotec Global PLC, a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced third quarter 2017 financial results.
“We are pleased to report another strong quarter, with solid growth across both franchises and all three geographies served,” said Dr. Peter Wrighton-Smith, Chief Executive Officer of Oxford Immunotec. “As we move forward through the remainder of the year and into 2018, we will continue to focus on driving revenue growth and progressing the company towards profitability.”
By revenue type, total revenues were, in millions:
Three Months Ended September 30,
Read the rest of entry »
This year’s SITC is taking place 8 – 12 November, 2017, at the Gaylord National Resort & Convention Center in National Harbor, Maryland in USA.
AMSBIO announces the launch of a new service for synthesis of custom-designed, highly modified mRNAs prepared by an advantageous in vitro transcription methodology.
The BioHub Birmingham, the University of Birmingham’s flagship biomedical incubator, will be hosting a bio-networking showcase and event on November 8th from 3.30 – 5.00pm.
Platelet Solutions Ltd., Nottingham is pleased to announce the successful achievement of CE marking for its Platelet Function Testing Kits (PSK-001/002/003).
Wickham Laboratories expands capacity for in-house media preparation.
AMSBIO announces the launch of two new microplate-based metabolism stress kits enabling characterization of the main parameters of mitochondrial function in live cells and evaluation of the glycolytic response ofin vitro cell models to metabolic stress.
AMSBIO announces the launch of two new microplate-based metabolism stress kits enabling characterization of the main parameters of mitochondrial function in live cells and evaluation of the glycolytic response of in vitro cell models to metabolic stress
Announced that it plans to release third quarter 2017 financial results prior to market open.
Oxford, UK: Genomics plc today announced that it has entered into a collaborative deal with Biogen, Inc., the U.S.-based biotech, to work on multiple sclerosis (MS). Biogen is an international leader in drug therapies for MS, with the broadest MS portfolio in the industry.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.